C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/1999
12/29/1999	WO1999058647A3 Human deadenylating nuclease, its production and its use
12/29/1999	WO1999058639A3 Structural proteins of fish pancreatic disease virus and uses thereof
12/29/1999	WO1999058563A3 Moraxella catharralis proteins
12/29/1999	WO1999057320B1 Antisense modulation of cd40 expression
12/29/1999	WO1999057284A3 Attenuated influenza viruses
12/29/1999	WO1999057140A3 Growth-associated protease inhibitor heavy chain precursor
12/29/1999	WO1999055908A3 Nucleotide sequences for detecting enterohemorrhagic escherichia coli (ehec)
12/29/1999	WO1999054436A3 Nucleic acids and proteins of c. elegans insulin-like genes and uses thereof
12/29/1999	WO1999051779A3 Glaucoma therapeutics and diagnostics
12/29/1999	WO1999049774A3 Methods for the diagnosis and treatment of lung cancer
12/29/1999	WO1999049050A3 Limanthes oil genes
12/29/1999	WO1999049010A3 Phenol oxidizing enzymes and their use
12/29/1999	WO1999047156A3 Compositions for modulating cell differentiation comprising a lipid and a morphogen
12/29/1999	WO1999043802A3 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
12/29/1999	WO1999041390A8 Expression vector for the production of dead proteins
12/29/1999	WO1999037755A3 The use of consensus sequences for targeted homologous gene isolation and recombination in gene families
12/29/1999	WO1998055150A8 Txu-7-pap immunotoxin and use thereof
12/29/1999	WO1997040147A8 Antigenically reactive regions of the hepatitis a virus polyprotein
12/29/1999	EP0967291A1 Method for parallel screening of allelic variation
12/29/1999	EP0967289A1 Improvements in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor
12/29/1999	EP0967288A1 Transfection system for the transfer of nucleic acids into cells
12/29/1999	EP0967287A2 Overproduction of riboflavin in yeast
12/29/1999	EP0967286A2 Leucine aminopeptidase gene, recombinant dna, and process for producing leucine aminopeptidase
12/29/1999	EP0967285A1 Prolylendopeptidase from Flavobacterium meningosepticum
12/29/1999	EP0967284A1 Phosphodiesterases
12/29/1999	EP0967283A1 Genes encoding proteins having transglycosylation activity
12/29/1999	EP0967282A2 Cytochrome bd type quinol oxidase gene of Brevibacterium lactofermentum
12/29/1999	EP0967280A1 Yeast strains with fil phenotype, stress resistant under conditions of growth and/or fermentation
12/29/1999	EP0967279A1 Helicobacter pylori cytotoxin useful for vaccines and diagnostics
12/29/1999	EP0967278A2 Flowering regulating gene and its use
12/29/1999	EP0967277A2 Production of chimeric mouse-human antibodies with specificity to human tumor antigens
12/29/1999	EP0967276A2 Anti-tumor agent comprising salmosin
12/29/1999	EP0967275A1 Dna sequences enhancing promoter activity
12/29/1999	EP0967274A2 Method for purification of covalently closed DNA-molecules
12/29/1999	EP0967273A1 Cell supporting matrix, cell culture device, and fluid treating device
12/29/1999	EP0967271A1 Novel carbonyl reductase, gene that encodes the same, and method of utilizing these
12/29/1999	EP0967226A2 Methods for the production of fibrillar collagen
12/29/1999	EP0967225A1 ATP-sensitive potassium channel gene (Kir6.2/BIR)-deficient animals
12/29/1999	EP0967224A1 Novel protein, its gene, reagents for inducing apoptosis, and anticancer agents
12/29/1999	EP0967218A1 Silica-guanidiniumthiocyanate DNA isolation using casein
12/29/1999	EP0967217A2 Reagents and methods for solid phase synthesis and display
12/29/1999	EP0966685A1 Protein fragment complementation assays to detect biomolecular interactions
12/29/1999	EP0966545A2 Method for typing of minor histocompatibility antigen ha-1
12/29/1999	EP0966542A1 Fen-1 endonucleases, mixtures and cleavage methods
12/29/1999	EP0966541A1 Method and constructs for inhibiting protein expression in bacteria
12/29/1999	EP0966538A1 Replication-competent recombinant sabin type 1 strain of poliovirus
12/29/1999	EP0966537A2 AN $i(EX VIVO) ANIMAL OR CHALLENGE MODEL AS METHOD TO MEASURE PROTECTIVE IMMUNITY DIRECTED AGAINST PARASITES AND VACCINES SHOWN TO BE PROTECTIVE IN SAID METHOD
12/29/1999	EP0966536A1 Factor x analogues with a modified protease cleavage site
12/29/1999	EP0966535A1 Epitopes of the protein pre-m/m of the dengue virus, synthetic peptides
12/29/1999	EP0966534A1 Compositions and methods for elimination of unwanted cells
12/29/1999	EP0966533A1 Activity dependent neurotrophic factor iii (adnf iii)
12/29/1999	EP0966532A1 Biological material for treating a mammal by antibody gene transfer and pharmaceutical composition containing same
12/29/1999	EP0966531A1 Tazarotene-induced gene 3 (tig3)
12/29/1999	EP0966530A2 Secreted proteins and polynucleotides encoding them
12/29/1999	EP0966528A1 Surrogate genetics target characterization method
12/29/1999	EP0966527A1 Method for inducing mutations and the use thereof in the production of a vaccine against pathogenic microorganisms
12/29/1999	EP0966524A1 A process for purification of pcr test samples
12/29/1999	EP0966523A1 Method for the production of selected lymphocytes
12/29/1999	EP0966522A1 Human liver cell line
12/29/1999	EP0966521A1 Cells having dna insertion mutations which produce altered amounts of a polypeptide
12/29/1999	EP0966485A1 MUTATED NONACTIVATING IgG2 DOMAINS AND ANTI-CD3 ANTIBODIES INCORPORATING THE SAME
12/29/1999	EP0966484A1 Neurotactin and uses therefor
12/29/1999	EP0966481A2 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
12/29/1999	EP0966480A2 Cysteine-depleted peptides recognized by a3-restricted cytotoxic lymphocytes, and uses therefor
12/29/1999	EP0966478A1 Novel hedgehog-derived polypeptides
12/29/1999	EP0966206A2 Frozen food product containing antifreeze peptides
12/29/1999	EP0868716A4 Method for recovering data from disk with magneto-resistive head in presence of thermal asperities
12/29/1999	EP0851922B1 Cyclin depenpent kinase binding compounds
12/29/1999	EP0822993B1 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene kai1
12/29/1999	EP0781327A4 Production of hydroxylated fatty acids in genetically modified plants
12/29/1999	EP0774005B1 Surface expression of enzyme in gene directed prodrug therapy
12/29/1999	EP0751788B1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug
12/29/1999	EP0705271A4 Hybridization and sequencing of nucleic acids
12/29/1999	EP0668781B1 Lymphokine gene therapy of cancer in combination with tumor antigens
12/29/1999	EP0635062B1 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS OF mRNA
12/29/1999	EP0625213B1 Assay methods
12/29/1999	EP0625048B1 Synthesis of human procollagens and collagens in recombinant dna systems
12/29/1999	EP0564645B1 Transformant cells for the prophylaxis or treatment of diseases caused by viruses, particularly pathogenic retroviruses
12/29/1999	EP0556292B1 Hepatitis c virus asialoglycoproteins
12/29/1999	CN1240002A Strain belonging to genus bacillus and insecticidal proteins
12/29/1999	CN1240001A Mutants of streptococcal toxin C and methods of use
12/29/1999	CN1240000A Polypeptides encoded by human lipase-like gene, compositions and methods
12/29/1999	CN1239997A Methods of preserving prokaryotic cells and compositions obtained thereby
12/29/1999	CN1047794C Recombination double-cistron expressing plasmid, and its preparing process and use
12/29/1999	CA2690395A1 Use of bi-specific antibodies for pre-targeting diagnosis and therapy
12/29/1999	CA2618288A1 Antisense oligonucleotide constructs based on .beta.-arabinofuranose and its analogues
12/29/1999	CA2341679A1 Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
12/29/1999	CA2335804A1 Allelic series of genomic modifications in cells
12/29/1999	CA2335585A1 Novel molecules of the t110-related protein family and uses thereof
12/29/1999	CA2335562A1 Production of polymers from nucleotidic and/or non-nucleotidic elements using enzymatic methods
12/29/1999	CA2335522A1 Water stress or salt stress tolerant transgenic cereal plants
12/29/1999	CA2334645A1 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism
12/29/1999	CA2332643A1 Dna encoding oat acetyl coa carboxylase
12/29/1999	CA2332180A1 Overexpression of phytase genes in yeast systems
12/29/1999	CA2331924A1 Propionibacterium vector
12/29/1999	CA2331923A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
12/29/1999	CA2331921A1 A novel invertebrate intestinal mucin cdna and related products and methods
12/29/1999	CA2331920A1 Hcv-derived rna polymerase gene
12/29/1999	CA2331919A1 Structured antisense nucleic acid molecules
12/29/1999	CA2331890A1 Method and medium for in vitro culture of human embryos

1 ... 3306 3307 3308 3309 3310 3311 3312 3313 3314 3315 3316 3317 3318 3319 3320 3321 3322 3323 3324 3325 3326 ... 4023